top of page

Gastrointestinal Stromal Tumor Day

Gastrointestinal Stromal Tumor (GIST) is an uncommon form of cancer that affects the gastrointestinal tract. GIST Day, observed annually on July 13th, is an important platform to educate, inspire, and advocate for patients and their loved ones.

Gastrointestinal Stromal Tumors are abnormal cell growths that originate in the walls of the gastrointestinal tract, commonly in the stomach and small intestine. While some GISTs can be benign, many cases are malignant and require prompt medical attention.

GIST grows slowly and spreads slowly, leading to symptoms such as blood in vomit or stools. Early detection plays a crucial role in improving treatment outcomes. Advances in GIST research have led to improved surgical interventions. In cases where the tumour is located in critical areas, such as near blood vessels, chemotherapy may be administered to shrink the tumour before surgery.

As a tertiary cancer care centre, we understand challenges faced by patients with GIST and provide top-of-the-line treatment to cater to all their needs. Our doctors use cutting-edge treatments that leave GIST patients with a 90-95% survival rate in the first stage and up to 56% in the fourth stage.

GIST can have profound impact on patients, both physically and emotionally. Patients often experience pain, fatigue, and nutritional challenges. We prioritise comprehensive care, addressing not only the physical aspects of the disease but also providing support to enhance the overall well-being of GIST patients. Our multidisciplinary approach ensures patients receive personalised care that addresses their specific needs.

Gastrointestinal Stromal Tumor Day is a significant occasion that sheds light on the challenges those living with GIST face. By raising awareness, providing expert care, and offering support, we can make a significant difference in the lives of GIST patients. Let us join hands on July 13th and throughout the year to empower GIST patients, spread hope, and strive towards a future with improved treatments and outcomes.

At SSCHRC, we are committed to providing GIST patients with the highest quality of care, promoting research, and fostering a compassionate and supportive environment. Together, we can make a meaningful impact in the lives of all individuals and families affected by cancer.

- Complied by: Pratha Narayan


Recent Posts

See All


bottom of page